Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate

Author： Rosen Steven D Lemjabbar-Alaoui Hassan

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.9, 2010-09, pp. : 935-949

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Grb2 signaling in cell motility and cancer

By Giubellino Alessio Burke Terrence R Bottaro Donald P

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 1021-1033

Informa Healthcare

Access to resources Recommend Favorite

Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 191-196

Bentham Science Publishers

Access to resources Recommend Favorite

NOTCH Signaling as a Novel Cancer Therapeutic Target

Current Cancer Drug Targets, Vol. 6, Iss. 4, 2006-06 ,pp. : 313-323

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer heterogeneity and signaling network-based drug target

By Roukos Dimitrios H

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1243-1246

Future Medicine

Access to resources Recommend Favorite

Notch Signaling: A Potential Therapeutic Target in Prostate Cancer

Current Cancer Drug Targets, Vol. 8, Iss. 7, 2008-11 ,pp. : 566-580

Bentham Science Publishers

Access to resources Recommend Favorite